Target Price Playground
BIO.B
$389.98
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on BIO.B? Launch with your exact active legs & +10.0% target.
Forward Projection
If price hits $429 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Own stock + buy put as insurance against downside.
๐ฏ Target
1-Click Institutional Target Anchors:
54d from today
โ๏ธ Legs
LONG 100 SHARES
@ $389.98 ยท ฮ 1.00
LONG PUT ยท $370 ยท Jan '27
Qty 1 ยท Premium $8.45 ยท ฮ -0.28
P&L at Expiry
Stock (100 sh)
Protective Put
Now
Target
๐ก Stock vs Options at Target
If BIO.B hits $429 by Jan 15: the protective put returns +$3,055 (7.7%) on $39,843 risked, vs +$3,900 (10.0%) for 100 shares on $38,998. Options give 0.8ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (54 days out). P&L shown is the value at expiry if BIO.B is at $429.
๐ Projected Return
P&L if BIO.B hits $429 by Jan 15
+$3,055
+7.7% on $39,843 risked
Max Profit
Unlimited
Unlimited upside (minus put cost)
Max Loss
โ$2,843
Put floors you at $370
Break-even
$398.43
+2.17% from spot
Prob. of Profit at Expiry (PoP)
42.6%
Above breakeven ($398.43)
ยท Touch Target: 39%
30-Day Theta Burn (If Flat)
โ$380
1.0% of entry cost ยท Daily ฮ: $-12.65/day
Net ฮ / ฮ / V
71.61 / -12.65 / 50.83
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| BIO.B Price | Today | +3d (Nov 25) | +7d (Nov 29) | Dec 10 | Dec 28 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $312 (-20%) | -$2,952 | -$2,955 | -$2,957 | -$2,957 | -$2,921 | -$2,843 |
| $331 (-15%) | -$2,681 | -$2,700 | -$2,724 | -$2,790 | -$2,873 | -$2,843 |
| $351 (-10%) | -$2,134 | -$2,168 | -$2,214 | -$2,351 | -$2,616 | -$2,843 |
| $370 (-5%) | -$1,240 | -$1,281 | -$1,338 | -$1,511 | -$1,876 | -$2,795 |
| $382 (-2%) | -$535 | -$575 | -$631 | -$800 | -$1,145 | -$1,625 |
| $390 (0%) โ spot | +$0 | -$38 | -$91 | -$249 | -$553 | -$845 |
| $398 (+2%) | +$581 | +$545 | +$497 | +$356 | +$103 | -$65 |
| $409 (+5%) | +$1,525 | +$1,495 | +$1,455 | +$1,344 | +$1,172 | +$1,105 |
| $429 (+10%) โ target | +$3,246 | +$3,227 | +$3,202 | +$3,138 | +$3,066 | +$3,055 |
| $448 (+15%) | +$5,085 | +$5,075 | +$5,061 | +$5,030 | +$5,006 | +$5,005 |
| $468 (+20%) | +$6,986 | +$6,981 | +$6,975 | +$6,962 | +$6,955 | +$6,955 |
Uses BIO.B's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.